Compare KRYS & KEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | KEX |
|---|---|---|
| Founded | 2015 | 1921 |
| Country | United States | United States |
| Employees | 295 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.6B |
| IPO Year | 2017 | 1994 |
| Metric | KRYS | KEX |
|---|---|---|
| Price | $324.39 | $141.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $297.60 | $137.25 |
| AVG Volume (30 Days) | 229.9K | ★ 517.4K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.00 | 28.92 |
| EPS | ★ 1.83 | 1.50 |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $4.34 |
| Revenue Next Year | $32.53 | $7.61 |
| P/E Ratio | $177.46 | ★ $94.67 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $127.99 | $79.52 |
| 52 Week High | $331.49 | $157.69 |
| Indicator | KRYS | KEX |
|---|---|---|
| Relative Strength Index (RSI) | 64.27 | 47.71 |
| Support Level | $253.89 | $140.13 |
| Resistance Level | N/A | $145.60 |
| Average True Range (ATR) | 11.46 | 3.24 |
| MACD | 1.21 | -0.12 |
| Stochastic Oscillator | 84.04 | 48.66 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's majority revenue is generated from the Marine Transportation segment.